Technology
Novel combination therapy approach to keep leukemia at bay – News-Medical.Net
In chronic leukemias, blocking the overactive kinase JAK2 by a targeted therapy approach is only mitigating the patients’ symptoms,…
In chronic leukemias, blocking the overactive kinase JAK2 by a targeted therapy approach is only mitigating the patients’ symptoms, but cannot truly change the course of the disease. A study by the University of Basel has shown that it may be possible to…
Continue Reading
-
Noosa News21 hours agoWoman was watching keepers work when lion attacked, Darling Downs Zoo says
-
Noosa News20 hours agoWorking for someone else made it hard to care for my daughter. So I quit
-
General16 hours ago‘Potential’ hacker contacts Qantas over data breach
-
Noosa News23 hours agoStar Entertainment faces $36.5m blow if Queen’s Wharf deal flops